Cargando…

Ofatumumab for the treatment of refractory anti‐LGI1 encephalitis with long‐term poor blood glucose control in type 1 diabetes

Detalles Bibliográficos
Autores principales:	Chen, Kaili, Yang, Le, Xu, Lei, Jiang, Yan, He, Jinting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651958/ https://www.ncbi.nlm.nih.gov/pubmed/37602875 http://dx.doi.org/10.1111/cns.14416

Ejemplares similares

Striatum Involvement in LGI1 Limbic Encephalitis
por: Plantone, Domenico
Publicado: (2018)

Psychiatric Manifestation of Anti-LGI1 Encephalitis
por: Endres, Dominique, et al.
Publicado: (2020)

Anti-LGI1 Encephalitis Presented With Prominent Psychosis Without Loss of Consciousness
por: Cho, Ja Hyeon, et al.
Publicado: (2023)

LGI1 Encephalitis: Autoimmune Epilepsy or Movement Disorder
por: Jagtap, Sujit A., et al.
Publicado: (2023)

Anti-LGI1 encephalitis following COVID-19 vaccination: a case series
por: Asioli, Gian Maria, et al.
Publicado: (2022)

Anti-LGI1 encephalitis with initiating symptom of seizures in children
por: Wang, Yang, et al.
Publicado: (2023)

Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
por: Cui, Li-li, et al.
Publicado: (2021)

Rapidly Progressive Cognitive Impairment with Faciobrachial Dystonic Seizures (FBDS) in Anti-LGI1 Encephalitis
por: Yin, Weifang, et al.
Publicado: (2022)

LGI1-Antibody Associated Autoimmune Encephalitis Complicated by Primary Polydipsia
por: Yaqoob, Arjimand, et al.
Publicado: (2022)

Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
por: Lee, Jung-Ju, et al.
Publicado: (2013)

Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2021)

Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis
por: Feng, Jingjing, et al.
Publicado: (2021)

Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis
por: Zhong, Rui, et al.
Publicado: (2022)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Case Report: Anti-LGI1 Limbic Encephalitis Associated With Anti-thyroid Autoantibodies
por: Otiniano-Sifuentes, Ricardo, et al.
Publicado: (2021)

Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination
por: Zlotnik, Yair, et al.
Publicado: (2022)

Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis
por: Sadaghiani, Mohammad S., et al.
Publicado: (2023)

Hyponatraemia caused by LGI1-associated limbic encephalitis
por: McQuillan, Rory F., et al.
Publicado: (2011)

Clinical features of limbic encephalitis with LGI1 antibody
por: Wang, Meiling, et al.
Publicado: (2017)

Pilomotor Seizures in a Patient With LGI1 Encephalitis
por: Yang, Jinxia, et al.
Publicado: (2020)

Flortaucipir (tau) PET in LGI1 antibody encephalitis
por: Day, Gregory S., et al.
Publicado: (2021)

Primary B Cell Lymphoma of the CNS Mimicking Anti-LGI1 Limbic Encephalitis
por: Thomas, Christian, et al.
Publicado: (2018)

Recognition of seizure semiology and semiquantitative FDG‐PET analysis of anti‐LGI1 encephalitis
por: Li, Tao‐Ran, et al.
Publicado: (2021)

Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission
por: Orimo, Kenta, et al.
Publicado: (2020)

The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined
por: Muñoz-Sánchez, Guillermo, et al.
Publicado: (2022)

New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 Encephalitis
por: Segal‬‏, Yahel, et al.
Publicado: (2023)

Fire acupuncture for anti-LGI1 antibody autoimmune encephalitis: a case report
por: Liu, Yu, et al.
Publicado: (2023)

Efficacy of immunotherapy and prognosis in anti‐LGI1 encephalitis patients: A meta‐analysis
por: Kong, Xueying, et al.
Publicado: (2023)

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA(B)R encephalitis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2019)

Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABA(B)R encephalitis
por: Shen, Chun‐Hong, et al.
Publicado: (2020)

Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study
por: Zhong, Rui, et al.
Publicado: (2022)

Intrathecal B-cell activation in LGI1 antibody encephalitis
por: Lehmann-Horn, Klaus, et al.
Publicado: (2020)

Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies
por: Qiao, Jianping, et al.
Publicado: (2020)

LGI1 antibody encephalitis: acute treatment comparisons and outcome
por: Rodriguez, Andrew, et al.
Publicado: (2022)

Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis
por: Ludewig, Susann, et al.
Publicado: (2023)

Clinical Characteristics of Cognitive Impairment and 1-Year Outcome in Patients With Anti-LGI1 Antibody Encephalitis
por: Hang, Hai-lun, et al.
Publicado: (2020)

A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies
por: Ji, Tuo, et al.
Publicado: (2020)

Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis
por: Rissanen, Eero, et al.
Publicado: (2022)

Thymoma-associated anti-LGI1 encephalitis and myasthenia gravis: A unique combination with autoantibodies
por: Satake, Akane, et al.
Publicado: (2022)

Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis
por: Qiao, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qd7grp0f9ggdeflk00v3rncb6